Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Members of Congress are headed back to their districts this week to campaign ahead of the November elections without unveiling [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital group recently hit back against the drug industry’s claims that hospital behavior has helped drive “out of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The sponsor of new Senate legislation that would codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Vermont Democrat has introduced Senate legislation to codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...] …
